Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
The aim was to better understand the clinical characteristics of patients with mucormycosis in western China. We retrospectively investigated the clinical, laboratory, radiological and treatment profiles of mucormycosis patients during a 10-year period (2010–2019). As a result, 59 proven mucormycosi...
Enregistré dans:
Auteurs principaux: | Junyan Qu, Xijiao Liu, Xiaoju Lv |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a047d29131a94e8d90d6258debe8b85f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
par: F. Yuan, et autres
Publié: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
par: Nagehan Didem Sarı, et autres
Publié: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
par: Vivek Pai, et autres
Publié: (2021) -
First reported case of late recurrence of pulmonary mucormycosis in a renal transplant recipient with poorly controlled diabetes mellitus
par: Cheuk Cheung Derek Leung, et autres
Publié: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
par: Tonya N. Watkins, et autres
Publié: (2018)